APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucagon Like Peptide 2 Receptor

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Glucagon Like Peptide 2 Receptor Industry Growth and Trends Forecast to 2032

19 December 202597 pages

Choose your research edition.

Industry ResearchGlucagon Like Peptide 2 Receptor Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucagon Like Peptide 2 Receptor Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Glucagon Like Peptide 2 Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucagon Like Peptide 2 Receptor Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucagon Like Peptide 2 Receptor Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Glucagon Like Peptide 2 Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Glucagon Like Peptide 2 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Glucagon Like Peptide 2 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glucagon Like Peptide 2 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glucagon Like Peptide 2 Receptor include Takeda, Tasly Pharmaceutical Group Co Ltd, Hanmi Pharmaceuticals Co Ltd, Zealand Pharma AS and Naia Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Glucagon Like Peptide 2 Receptor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Glucagon Like Peptide 2 Receptor market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glucagon Like Peptide 2 Receptor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glucagon Like Peptide 2 Receptor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Glucagon Like Peptide 2 Receptor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Glucagon Like Peptide 2 Receptor Market by Company

Takeda

Tasly Pharmaceutical Group Co Ltd

Hanmi Pharmaceuticals Co Ltd

Zealand Pharma AS

Naia Ltd

Glucagon Like Peptide 2 Receptor Segment by Type

FE-203799

GXG-8

HM-15910

Glepaglutide

Others

Glucagon Like Peptide 2 Receptor Segment by Application

Diabetes

Diarrhea

Obesity

Short Bowel Syndrome

Others

Glucagon Like Peptide 2 Receptor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon Like Peptide 2 Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucagon Like Peptide 2 Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon Like Peptide 2 Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glucagon Like Peptide 2 Receptor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Glucagon Like Peptide 2 Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of FE-203799 Table 2. Major Company of GXG-8 Table 3. Major Company of HM-15910 Table 4. Major Company of Glepaglutide Table 5. Major Company of Others Table 6. Global Glucagon Like Peptide 2 Receptor Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Glucagon Like Peptide 2 Receptor Sales by Type (2021-2026) & (W Units) Table 8. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Type (2021-2026) Table 9. Global Glucagon Like Peptide 2 Receptor Sales by Type (2021-2026) & (US$ Million) Table 10. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Type (2021-2026) Table 11. Global Glucagon Like Peptide 2 Receptor Price by Type (2021-2026) & (US$/Unit) Table 12. Global Glucagon Like Peptide 2 Receptor Sales by Type (2027-2032) & (W Units) Table 13. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Type (2027-2032) Table 14. Global Glucagon Like Peptide 2 Receptor Sales by Type (2027-2032) & (US$ Million) Table 15. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Type (2027-2032) Table 16. Global Glucagon Like Peptide 2 Receptor Price by Type (2027-2032) & (US$/Unit) Table 17. North America Glucagon Like Peptide 2 Receptor Sales by Type (2021-2026) & (W Units) Table 18. North America Glucagon Like Peptide 2 Receptor Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Glucagon Like Peptide 2 Receptor Sales by Type (2021-2026) & (W Units) Table 20. Europe Glucagon Like Peptide 2 Receptor Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Glucagon Like Peptide 2 Receptor Sales by Type (2021-2026) & (W Units) Table 24. Latin America Glucagon Like Peptide 2 Receptor Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Type (2021-2026) & (US$ Million) Table 27. Glucagon Like Peptide 2 Receptor Industry Trends Table 28. Glucagon Like Peptide 2 Receptor Industry Drivers Table 29. Glucagon Like Peptide 2 Receptor Industry Opportunities and Challenges Table 30. Glucagon Like Peptide 2 Receptor Industry Restraints Table 31. Global Glucagon Like Peptide 2 Receptor Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Company (2021-2026) Table 33. Global Glucagon Like Peptide 2 Receptor Sales by Company (2021-2026) & (W Units) Table 34. Global Glucagon Like Peptide 2 Receptor Sales Share by Company (2021-2026) Table 35. Global Glucagon Like Peptide 2 Receptor Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Glucagon Like Peptide 2 Receptor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Glucagon Like Peptide 2 Receptor Major Company Production Sites and Headquarters Table 38. Global Glucagon Like Peptide 2 Receptor Company, Product Type & Application Table 39. Global Glucagon Like Peptide 2 Receptor Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Glucagon Like Peptide 2 Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Glucagon Like Peptide 2 Receptor Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Glucagon Like Peptide 2 Receptor Sales by Region (2021-2026) & (W Units) Table 44. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Region (2021-2026) Table 45. Global Glucagon Like Peptide 2 Receptor Sales by Region (2021-2026) & (US$ Million) Table 46. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Region (2021-2026) Table 47. Global Glucagon Like Peptide 2 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Glucagon Like Peptide 2 Receptor Sales by Region (2027-2032) & (W Units) Table 49. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Region (2027-2032) Table 50. Global Glucagon Like Peptide 2 Receptor Sales by Region (2027-2032) & (US$ Million) Table 51. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Region (2027-2032) Table 52. Global Glucagon Like Peptide 2 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Glucagon Like Peptide 2 Receptor Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Glucagon Like Peptide 2 Receptor Sales by Application (2021-2026) & (W Units) Table 55. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Application (2021-2026) Table 56. Global Glucagon Like Peptide 2 Receptor Sales by Application (2021-2026) & (US$ Million) Table 57. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Application (2021-2026) Table 58. Global Glucagon Like Peptide 2 Receptor Price by Application (2021-2026) & (US$/Unit) Table 59. Global Glucagon Like Peptide 2 Receptor Sales by Application (2027-2032) & (W Units) Table 60. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Application (2027-2032) Table 61. Global Glucagon Like Peptide 2 Receptor Sales by Application (2027-2032) & (US$ Million) Table 62. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Application (2027-2032) Table 63. Global Glucagon Like Peptide 2 Receptor Price by Application (2027-2032) & (US$/Unit) Table 64. North America Glucagon Like Peptide 2 Receptor Sales by Application (2021-2026) & (W Units) Table 65. North America Glucagon Like Peptide 2 Receptor Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Glucagon Like Peptide 2 Receptor Sales by Application (2021-2026) & (W Units) Table 67. Europe Glucagon Like Peptide 2 Receptor Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Glucagon Like Peptide 2 Receptor Sales by Application (2021-2026) & (W Units) Table 71. Latin America Glucagon Like Peptide 2 Receptor Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Application (2021-2026) & (US$ Million) Table 74. Takeda Company Information Table 75. Takeda Business Overview Table 76. Takeda Glucagon Like Peptide 2 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Takeda Glucagon Like Peptide 2 Receptor Product Portfolio Table 78. Takeda Recent Development Table 79. Tasly Pharmaceutical Group Co Ltd Company Information Table 80. Tasly Pharmaceutical Group Co Ltd Business Overview Table 81. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Product Portfolio Table 83. Tasly Pharmaceutical Group Co Ltd Recent Development Table 84. Hanmi Pharmaceuticals Co Ltd Company Information Table 85. Hanmi Pharmaceuticals Co Ltd Business Overview Table 86. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Product Portfolio Table 88. Hanmi Pharmaceuticals Co Ltd Recent Development Table 89. Zealand Pharma AS Company Information Table 90. Zealand Pharma AS Business Overview Table 91. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Product Portfolio Table 93. Zealand Pharma AS Recent Development Table 94. Naia Ltd Company Information Table 95. Naia Ltd Business Overview Table 96. Naia Ltd Glucagon Like Peptide 2 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Naia Ltd Glucagon Like Peptide 2 Receptor Product Portfolio Table 98. Naia Ltd Recent Development Table 99. North America Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 100. North America Glucagon Like Peptide 2 Receptor Sales by Country (2021-2026) & (W Units) Table 101. North America Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2021-2026) Table 102. North America Glucagon Like Peptide 2 Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 103. North America Glucagon Like Peptide 2 Receptor Sales Market Share Forecast by Country (2027-2032) Table 104. North America Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. North America Glucagon Like Peptide 2 Receptor Market Size by Country (2021-2026) & (US$ Million) Table 106. North America Glucagon Like Peptide 2 Receptor Market Share by Country (2021-2026) Table 107. North America Glucagon Like Peptide 2 Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. North America Glucagon Like Peptide 2 Receptor Market Share Forecast by Country (2027-2032) Table 109. Europe Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 110. Europe Glucagon Like Peptide 2 Receptor Sales by Country (2021-2026) & (W Units) Table 111. Europe Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2021-2026) Table 112. Europe Glucagon Like Peptide 2 Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 113. Europe Glucagon Like Peptide 2 Receptor Sales Market Share Forecast by Country (2027-2032) Table 114. Europe Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Europe Glucagon Like Peptide 2 Receptor Market Size by Country (2021-2026) & (US$ Million) Table 116. Europe Glucagon Like Peptide 2 Receptor Market Share by Country (2021-2026) Table 117. Europe Glucagon Like Peptide 2 Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Europe Glucagon Like Peptide 2 Receptor Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales by Country (2021-2026) & (W Units) Table 121. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2021-2026) Table 122. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 123. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific Glucagon Like Peptide 2 Receptor Market Size by Country (2021-2026) & (US$ Million) Table 126. Asia-Pacific Glucagon Like Peptide 2 Receptor Market Share by Country (2021-2026) Table 127. Asia-Pacific Glucagon Like Peptide 2 Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Asia-Pacific Glucagon Like Peptide 2 Receptor Market Share Forecast by Country (2027-2032) Table 129. Latin America Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 130. Latin America Glucagon Like Peptide 2 Receptor Sales by Country (2021-2026) & (W Units) Table 131. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2021-2026) Table 132. Latin America Glucagon Like Peptide 2 Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 133. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share Forecast by Country (2027-2032) Table 134. Latin America Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Latin America Glucagon Like Peptide 2 Receptor Market Size by Country (2021-2026) & (US$ Million) Table 136. Latin America Glucagon Like Peptide 2 Receptor Market Share by Country (2021-2026) Table 137. Latin America Glucagon Like Peptide 2 Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Latin America Glucagon Like Peptide 2 Receptor Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country (2021-2026) & (W Units) Table 141. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2021-2026) Table 142. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Forecast by Country (2027-2032) & (W Units) Table 143. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa Glucagon Like Peptide 2 Receptor Market Size by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Glucagon Like Peptide 2 Receptor Market Share by Country (2021-2026) Table 147. Middle East and Africa Glucagon Like Peptide 2 Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Middle East and Africa Glucagon Like Peptide 2 Receptor Market Share Forecast by Country (2027-2032) Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Glucagon Like Peptide 2 Receptor Distributors List Table 152. Glucagon Like Peptide 2 Receptor Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Glucagon Like Peptide 2 Receptor Image Figure 2. Global Glucagon Like Peptide 2 Receptor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucagon Like Peptide 2 Receptor Market Size (2021-2032) & (US$ Million) Figure 4. Global Glucagon Like Peptide 2 Receptor Sales (2021-2032) & (W Units) Figure 5. FE-203799 Image Figure 6. Global FE-203799 Sales YoY Growth (2021-2032) & (W Units) Figure 7. GXG-8 Image Figure 8. Global GXG-8 Sales YoY Growth (2021-2032) & (W Units) Figure 9. HM-15910 Image Figure 10. Global HM-15910 Sales YoY Growth (2021-2032) & (W Units) Figure 11. Glepaglutide Image Figure 12. Global Glepaglutide Sales YoY Growth (2021-2032) & (W Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global Glucagon Like Peptide 2 Receptor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Glucagon Like Peptide 2 Receptor Market Share by Type 2025 VS 2032 Figure 17. North America Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Type in 2025 Figure 18. North America Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Type in 2025 Figure 19. Europe Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Type in 2025 Figure 20. Europe Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Type in 2025 Figure 23. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Glucagon Like Peptide 2 Receptor Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Diabetes Image Figure 30. Global Diabetes Sales YoY Growth (2021-2032) & (W Units) Figure 31. Diarrhea Image Figure 32. Global Diarrhea Sales YoY Growth (2021-2032) & (W Units) Figure 33. Obesity Image Figure 34. Global Obesity Sales YoY Growth (2021-2032) & (W Units) Figure 35. Short Bowel Syndrome Image Figure 36. Global Short Bowel Syndrome Sales YoY Growth (2021-2032) & (W Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 39. Global Glucagon Like Peptide 2 Receptor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Glucagon Like Peptide 2 Receptor Market Share by Application 2025 VS 2032 Figure 41. North America Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Application in 2025 Figure 42. North America Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Application in 2025 Figure 43. Europe Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Application in 2025 Figure 44. Europe Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Application in 2025 Figure 47. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Application in 2025 Figure 51. North America Glucagon Like Peptide 2 Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. North America Glucagon Like Peptide 2 Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Glucagon Like Peptide 2 Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Glucagon Like Peptide 2 Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Glucagon Like Peptide 2 Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Europe Glucagon Like Peptide 2 Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Glucagon Like Peptide 2 Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Glucagon Like Peptide 2 Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Glucagon Like Peptide 2 Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Glucagon Like Peptide 2 Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Glucagon Like Peptide 2 Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Latin America Glucagon Like Peptide 2 Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Glucagon Like Peptide 2 Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Glucagon Like Peptide 2 Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 68. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Glucagon Like Peptide 2 Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Glucagon Like Peptide 2 Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Glucagon Like Peptide 2 Receptor Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Glucagon Like Peptide 2 Receptor Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • FE-203799
  • GXG-8
  • HM-15910
  • Glepaglutide
  • Others
Applications
  • Diabetes
  • Diarrhea
  • Obesity
  • Short Bowel Syndrome
  • Others
Companies covered
  • Takeda
  • Tasly Pharmaceutical Group Co Ltd
  • Hanmi Pharmaceuticals Co Ltd
  • Zealand Pharma AS
  • Naia Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glucagon Like Peptide 2 Receptor Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Glucagon Like Peptide 2 Receptor Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Glucagon Like Peptide 2 Receptor Market by Type
  6. 1.3.1 FE-203799
  7. 1.3.2 GXG-8
  8. 1.3.3 HM-15910
  9. 1.3.4 Glepaglutide
  10. 1.3.5 Others
  11. 1.4 Global Glucagon Like Peptide 2 Receptor Market Size by Type
  12. 1.4.1 Global Glucagon Like Peptide 2 Receptor Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Glucagon Like Peptide 2 Receptor Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Glucagon Like Peptide 2 Receptor Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Glucagon Like Peptide 2 Receptor Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Glucagon Like Peptide 2 Receptor Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Glucagon Like Peptide 2 Receptor Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Glucagon Like Peptide 2 Receptor Industry Trends
  2. 2.2 Glucagon Like Peptide 2 Receptor Industry Drivers
  3. 2.3 Glucagon Like Peptide 2 Receptor Industry Opportunities and Challenges
  4. 2.4 Glucagon Like Peptide 2 Receptor Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Glucagon Like Peptide 2 Receptor Revenue (2021-2026)
  2. 3.2 Global Top Players by Glucagon Like Peptide 2 Receptor Sales (2021-2026)
  3. 3.3 Global Top Players by Glucagon Like Peptide 2 Receptor Price (2021-2026)
  4. 3.4 Global Glucagon Like Peptide 2 Receptor Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glucagon Like Peptide 2 Receptor Major Company Production Sites & Headquarters
  6. 3.6 Global Glucagon Like Peptide 2 Receptor Company, Product Type & Application
  7. 3.7 Global Glucagon Like Peptide 2 Receptor Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glucagon Like Peptide 2 Receptor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glucagon Like Peptide 2 Receptor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glucagon Like Peptide 2 Receptor Tier 1, Tier 2, and Tier 3
4 Glucagon Like Peptide 2 Receptor Regional Status and Outlook
  1. 4.1 Global Glucagon Like Peptide 2 Receptor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Glucagon Like Peptide 2 Receptor Historic Market Size by Region
  3. 4.2.1 Global Glucagon Like Peptide 2 Receptor Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Glucagon Like Peptide 2 Receptor Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Glucagon Like Peptide 2 Receptor Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Glucagon Like Peptide 2 Receptor Forecasted Market Size by Region
  7. 4.3.1 Global Glucagon Like Peptide 2 Receptor Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Glucagon Like Peptide 2 Receptor Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Glucagon Like Peptide 2 Receptor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Glucagon Like Peptide 2 Receptor by Application
  1. 5.1 Glucagon Like Peptide 2 Receptor Market by Application
  2. 5.1.1 Diabetes
  3. 5.1.2 Diarrhea
  4. 5.1.3 Obesity
  5. 5.1.4 Short Bowel Syndrome
  6. 5.1.5 Others
  7. 5.2 Global Glucagon Like Peptide 2 Receptor Market Size by Application
  8. 5.2.1 Global Glucagon Like Peptide 2 Receptor Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Glucagon Like Peptide 2 Receptor Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Glucagon Like Peptide 2 Receptor Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Glucagon Like Peptide 2 Receptor Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Glucagon Like Peptide 2 Receptor Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Glucagon Like Peptide 2 Receptor Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Glucagon Like Peptide 2 Receptor Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Tasly Pharmaceutical Group Co Ltd
  8. 6.2.1 Tasly Pharmaceutical Group Co Ltd Company Information
  9. 6.2.2 Tasly Pharmaceutical Group Co Ltd Business Overview
  10. 6.2.3 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Product Portfolio
  12. 6.2.5 Tasly Pharmaceutical Group Co Ltd Recent Developments
  13. 6.3 Hanmi Pharmaceuticals Co Ltd
  14. 6.3.1 Hanmi Pharmaceuticals Co Ltd Company Information
  15. 6.3.2 Hanmi Pharmaceuticals Co Ltd Business Overview
  16. 6.3.3 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Product Portfolio
  18. 6.3.5 Hanmi Pharmaceuticals Co Ltd Recent Developments
  19. 6.4 Zealand Pharma AS
  20. 6.4.1 Zealand Pharma AS Company Information
  21. 6.4.2 Zealand Pharma AS Business Overview
  22. 6.4.3 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Product Portfolio
  24. 6.4.5 Zealand Pharma AS Recent Developments
  25. 6.5 Naia Ltd
  26. 6.5.1 Naia Ltd Company Information
  27. 6.5.2 Naia Ltd Business Overview
  28. 6.5.3 Naia Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Naia Ltd Glucagon Like Peptide 2 Receptor Product Portfolio
  30. 6.5.5 Naia Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Glucagon Like Peptide 2 Receptor Sales by Country
  2. 7.1.1 North America Glucagon Like Peptide 2 Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Glucagon Like Peptide 2 Receptor Sales by Country (2021-2026)
  4. 7.1.3 North America Glucagon Like Peptide 2 Receptor Sales Forecast by Country (2027-2032)
  5. 7.2 North America Glucagon Like Peptide 2 Receptor Market Size by Country
  6. 7.2.1 North America Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Glucagon Like Peptide 2 Receptor Market Size by Country (2021-2026)
  8. 7.2.3 North America Glucagon Like Peptide 2 Receptor Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Glucagon Like Peptide 2 Receptor Sales by Country
  2. 8.1.1 Europe Glucagon Like Peptide 2 Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Glucagon Like Peptide 2 Receptor Sales by Country (2021-2026)
  4. 8.1.3 Europe Glucagon Like Peptide 2 Receptor Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Glucagon Like Peptide 2 Receptor Market Size by Country
  6. 8.2.1 Europe Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Glucagon Like Peptide 2 Receptor Market Size by Country (2021-2026)
  8. 8.2.3 Europe Glucagon Like Peptide 2 Receptor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales by Country
  2. 9.1.1 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Glucagon Like Peptide 2 Receptor Market Size by Country
  6. 9.2.1 Asia-Pacific Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Glucagon Like Peptide 2 Receptor Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Glucagon Like Peptide 2 Receptor Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Glucagon Like Peptide 2 Receptor Sales by Country
  2. 10.1.1 South America Glucagon Like Peptide 2 Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Glucagon Like Peptide 2 Receptor Sales by Country (2021-2026)
  4. 10.1.3 South America Glucagon Like Peptide 2 Receptor Sales Forecast by Country (2027-2032)
  5. 10.2 South America Glucagon Like Peptide 2 Receptor Market Size by Country
  6. 10.2.1 South America Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Glucagon Like Peptide 2 Receptor Market Size by Country (2021-2026)
  8. 10.2.3 South America Glucagon Like Peptide 2 Receptor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country
  2. 11.1.1 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Glucagon Like Peptide 2 Receptor Market Size by Country
  6. 11.2.1 Middle East and Africa Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Glucagon Like Peptide 2 Receptor Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Glucagon Like Peptide 2 Receptor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Glucagon Like Peptide 2 Receptor Value Chain Analysis
  2. 12.1.1 Glucagon Like Peptide 2 Receptor Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Glucagon Like Peptide 2 Receptor Production Mode & Process
  7. 12.2 Glucagon Like Peptide 2 Receptor Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Glucagon Like Peptide 2 Receptor Distributors
  10. 12.2.3 Glucagon Like Peptide 2 Receptor Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst